Skip to main content
Caplight Logo









Onego Bio

Onego Bio

Private
HelsinkiHealthcare & Life Scienceshttps://www.onego.bio/

Last Round

Series A

Extension

Jul 17, 2024

Est. Valuation

$84.8M

Total Funding Raised

$70.8M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Onego Bio is a food-biotech company that produces animal-free egg protein through precision fermentation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

precision fermentationanimal-free egg proteinovalbuminegg alternativefood techfood ingredientalternative proteinalt proteincellular agriculturefunctional ingredientfungal fermentationB2B ingredient suppliersustainable proteinTrichoderma reeseiCPG ingredient

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Onego Bio Comparables

Compare Onego Bio with similar companies based on industry and business-model similarity.

Onego Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
The EVERY Company
85%
Revyve
84%
PoLoPo
81%

Onego Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJul 17, 2024
Series AApr 2, 2024
GrantSep 7, 2022
SeedFeb 22, 2022

Key People

Founding team and executive leadership

Christopher Landowski

Co-Founder and CTO

Founding Team

Maija Itkonen

CEO & Co-founder

Founding Team

Onego Bio Investors

Notable investors and investment history

Onego Bio investors
InvestorRounds
Agronomics LimitedSeries A, Seed
European Innovation Council FundSeries A Extension
TesiSeries A
European Commission (Horizon Europe)Series A Extension
Business FinlandGrant, Series A
HoldixSeries A
EIT FoodSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 9, 2026

    Collaborating with Sigma Foods on egg-free protein solutions.

  • Feb 4, 2026

    Dr. Antti Vasara appointed to the board of directors.

Onego Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Onego Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Onego Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersHelsinki
Employee Range63
Year Founded2022
Last FundingJul 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?